ONCR || News

Screen for Barrett’s in all with central obesity?

Posted on: 17/06/2014 - 16:55

CHICAGO – The prevalence of erosive esophagitis and Barrett’s esophagus is comparable in individuals regardless of whether they have gastroesophageal reflux symptoms, according to a population-based...

Field of Interest: Oncology

Type: News Item

Cancer survivors have higher medical costs

Posted on: 12/06/2014 - 18:15

Average annual medical expenses for male cancer survivors were more than double those of men with no history of cancer in 2008-2011, while expenditures for female cancer survivors were 64% higher...

Field of Interest: Oncology

Type: News Item

Insomnia with very short sleep duration is a risk factor for cancer

Posted on: 11/06/2014 - 19:00

MINNEAPOLIS – People who have the type of insomnia characterized by a sharply shortened duration of sleep are at increased risk for cancer, a longitudinal cohort study showed. In the study of more...

Field of Interest: Oncology

Type: News Item

Two behavioral therapies are on par for alleviating insomnia in cancer survivors

Posted on: 05/06/2014 - 20:45

MINNEAPOLIS – Both cognitive behavioral therapy for insomnia and mindfulness-based stress reduction training lessened insomnia in a group of cancer survivors, although the former works faster, new...

Field of Interest: Oncology

Type: News Item

Dogs detect prostate cancer VOCs in urine

Posted on: 04/06/2014 - 20:20

ORLANDO – Specially trained dogs accurately detected specific prostate cancer volatile organic compounds in urine samples from patients with varying stages of disease and risk levels in a controlled...

Field of Interest: Oncology

Type: News Item

High rate of durable responses to pembrolizumab in metastatic melanoma

Posted on: 03/06/2014 - 19:35

CHICAGO – The investigational targeted agent pembrolizumab induced durable treatment responses in a high percentage of patients with advanced metastatic melanoma, in a phase I study. Of 411...

Field of Interest: Oncology

Type: News Item

VIDEO: New option arises for young women with hormone-sensitive breast cancer

Posted on: 02/06/2014 - 22:40

CHICAGO – The aromatase inhibitor exemestane is more effective than tamoxifen in preventing breast cancer recurrence in premenopausal women also receiving ovarian function suppression as adjuvant...

Field of Interest: Oncology

Type: News Item

VIDEO: New option arises for young women with hormone-sensitive breast cancer

Posted on: 02/06/2014 - 22:40

Field of Interest: Pulmonology

Type: News Item

VIDEO: Adding docetaxel up front improved survival in prostate cancer by more than a year

Posted on: 02/06/2014 - 20:50

CHICAGO –The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...

Field of Interest: Oncology

Type: News Item

Drug combo extends survival by more than 1 year in metastatic prostate cancer patients

Posted on: 02/06/2014 - 18:55

CHICAGO – The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...

Field of Interest: Oncology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters